Skip to content

Effect Of 12-Week Yogic Breathing on Risk Factors Of CVD In Adults With Metabolic Syndrome: A Randomised Controlled Trial

Effect Of 12-Week Yogic Breathing In Modulating The Conventional And Atypical Risk Factors Of CVD In Adults With Metabolic Syndrome: A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056540
Enrollment
72
Registered
2023-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

Intervention1: Yogic Breathing in addition to Standard care for Metabolic Syndrome.: 40 minutes Yogic breathing intervention for 12-week includes: 1.) Vibhaga pranayama (Adama, Madhyama and Adyama) wi

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.) Participants must be willing to give written consent and willing to comply with study protocol. 2.) Individuals diagnosed with MetS as per Joint Interim Statement (JIS), 2009, Criteria for the Clinical Diagnosis of MetS (Alberti, 2009): a.) hypertension, greater than or equal to 130/85 mmHg or use of hypertension drug, b.) reduced high-density lipoprotein cholesterol (HDL-C) of less than or equal to 40 mg/dL in males, 50 mg/dL in females or drug treatment for reduced HDL-C, c.) elevated triglycerides greater than or equal to 150 mg/dL, or drug treatment for elevated TG, d.) elevated fasting plasma glucose (FPG) greater than or equal to mg/dL or drug treatment for elevated glucose, e.) abdominal obesity, Waist circumference greater than or equal to 90 cm for male; 80 cm for female (for Asians)

Exclusion criteria

Exclusion criteria: 1.) Pregnant women, 2.) Alcoholism (will be assessed with AUDIT questionnaire, individuals who score more than 15 will be excluded) and smoking, 3.) Uncontrolled T2DM and/ or hypertension, 4.) Individuals diagnosed with severe psychiatric disorders like severe depression, anxiety, PTSD (self reported using the screening form), 5.) Any other major comorbidities like Post-stroke, Neuromusculoskeletal illnesses, Major orthopaedic diagnosis in the lower back, Pelvis or lower extremities, Pulmonary illnesses, Symptomatic heart disease, Symptomatic lung disease, chronic kidney disease (self reported using the screening form) 6.) Regular use of nonsteroidal anti-inflammatory drugs and antioxidant supplements, 7.) Regular Yoga(asanas/pranayama/meditation) practitioners (in the past 6 months) 8.) Individuals practising intense level physical activity (IPAQ questionnaire)

Design outcomes

Primary

MeasureTime frame
1.) Perceived Stress levels 2.) Blood Pressure (systolic/diastolic(mmHg) 3.) Serum Lipoprotein(a)Timepoint: 0 day and 12 weeks.

Secondary

MeasureTime frame
Self-Regulation of Eating Behaviour, Pittsburgh sleep quality index(Questionnaires), TG, HDL- C, FBS, Hba1c, hsCRP (assessed using automated analyser), Superoxide dismutase(SOD), OxLDL, FGF-21(ELISA kits), ECG/HRV.Timepoint: 0 day & 12 weeks.

Countries

India

Contacts

Public ContactDilasha Sethi

Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA)

mithila.mv@svyasa.edu.in8884597683

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026